Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Annals of Hematology|February 20, 2016
Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectivesMichele Malagola, Cristina Papayannidis, Michele BaccaraniLeukemia & Lymphoma|September 17, 2004
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?Giuseppe Visani, Michele Malagola, Pier Paolo Piccaluga, et al.Expert Review of Hematology|September 3, 2013
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary diseaseMario Malerba, Enrico Clini, Michele Malagola, et al.Therapeutic Advances in Hematology|December 25, 2023
Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patientDomenico Russo, Michele Malagola, Nicola Polverelli, et al.Journal of Clinical Medicine|April 26, 2025
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending?Mirko Farina, Michele Malagola, Simona Bernardi, et al.Current Cancer Drug Targets|August 15, 2013
Treatment of chronic myeloid leukemia elderly patients in the tyrosine kinase inhibitor eraDomenico Russo, Michele Malagola, Cristina Skert, et al.Leukemia Research|July 6, 2004
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patientsPier Paolo Piccaluga, Giovanni Martinelli, Michela Rondoni, et al.Haematologica|April 13, 2004
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likelyGiovanni Martinelli, Michela Rondoni, Silvia Buonamici, et al.Vaccines|May 26, 2026
Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational StudyRosa Daffini, Francesco Zecchini, Giulia Venneri, et al.Cells|February 15, 2022
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell TransplantationNicola Polverelli, Mirko Farina, Mariella D'Adda, et al.Pageof 11